Abstract
Aging is a significant risk factor for dry eye. Here we used a murine aging model to investigate the effects of aging on antigen presenting cells (APCs) and generation of pathogenic T helper (Th)-1 cells. Our results showed that APCs from aged mice accumulate at the conjunctiva, have higher levels of co-activation marker CD86 and lower aldehyde dehydrogenase activity. Using topical ovalbumin peptide as a surrogate antigen, we observed an increased number of antigen-loaded APCs in the draining cervical lymph nodes in the aged group and loss of tight junction protein occludin in the conjunctiva. Aged cervical lymph nodes APCs showed a greater generation of Th1 cells than young APCs in antigen-presentation assays in vitro. Aged lacrimal glands, and draining nodes showed an accumulation of IFN-γ producing CD4+T cells, while Th-17 cells were present only in aged draining nodes. There was also an age-related increase in CD4+CXCR3+IFN-γ+ cells in the conjunctiva, nodes, and lacrimal glands while CD4+CCR6+IL-17A+ cells increased in the draining nodes of aged mice. Adoptive transfer of aged CD4+CXCR3+ cells into young, naive immunodeficient recipients caused greater goblet cell loss than young CD4+CXCR3+ donor cells. Our results demonstrate that age-associated changes in APCs are critical for the pathogenesis of age-related dry eye.
Similar content being viewed by others
Introduction
Aging is the highest significant risk factor for dry eye. It has been reported that 6% of the population at the age of 40 and as many as 15–33% of elderly patients over the age of 65 are affected by the disease.1,2 Dry eye disease affects millions of people worldwide and is accompanied by ocular discomfort, blurred vision, loss of contrast sensitivity, and a decrease in functional vision.3
Age-related changes in the immune system are directly or indirectly related to increased risk of opportunistic infections, cancer, and autoimmunity in the elderly. Aging represents a state of paradox where chronic inflammation develops despite a decline in immune responses.4 While increased serum levels of TGF-β in centenarians can be considered a biomarker of good health,5 increased serum levels of IL-6, and TNF-α are predictors of disability and mortality in octogenarians and centenarians.6 Individual differences in regulating pro and anti-inflammatory cytokines may be critical in the outcome of inflammatory immune responses in the elderly.7 The changes in the immune system have profound consequences for survival and are reliable predictors of morbidity and mortality in the elderly.4
Because of its exposed location, the ocular surface mucosa provides a unique opportunity to study the inflammatory aspects of environmental stress in an aging population. Aged subjects have to cope with prolonged exposure to a myriad of antigens, which, in conjunction with a high inflammatory milieu, may stimulate antigen-presenting cells (APC) that are intimately connected to the environment and are essential initiators of the adaptive immune system. In experimental murine models of dry eye, depletion of APCs blunted the immune response and improved signs of dry eye disease.8 Increased expression of HLA-DR and its subsequent decrease after treatment has been used as an endpoint of clinical efficacy in several dry eye clinical trials.9,10,11
A body of evidence has identified that the T helper (Th)-1 signature cytokine IFN-γ has a pathogenic role in many autoimmune diseases, including dry eye. In the gut, IFN-γ promotes intestinal barrier loss.12,13 Increased levels of IFN-γ in tears, conjunctiva, saliva, and blood have been measured in patients with Sjögren Syndrome (SS) and non-SS associated dry eye disease and also in experimental models of dry eye.14,15,16,17 IFN-γ promotes apoptosis of lacrimal and salivary acini18,19 and conjunctival goblet cell dysfunction/loss.20,21,22 IFN-γ causes endoplasmic reticulum stress in cultured goblet cells and prevents appropriate folding and secretion of the murine Muc5ac protein.22 Furthermore, IFN-γ has been shown to block cholinergic-stimulated goblet cell secretion.23 Goblet cells secrete mucins but also immunoregulatory factors that can modulate dendritic cell activation.24,25,26 We have previously reported that aged C57BL/6J (B6) mice have dry eye disease27 and that age-associated increased IFN-γ expression contributes to goblet cell loss as IFN-γ knock-out mice were partially resistant to the aging, dry eye phenotype.28
The purpose of this study was to investigate how age-related changes in APCs participate in priming Th-1 cells. Our results indicate that aged APCs have a mature phenotype at the ocular surface, prime Th-1 cells in antigen-specific assays and Th-1 cells participate in the development of age-related dry eye associated pathology.
Results
Accumulation of dendritic cells with aging
Aging is a risk factor for dry eye disease. Our previous publication showed that aged B6 mice spontaneously develop dry eye.27 Because dry eye is more frequent in women,2,29 and aged male mice do not develop corneal barrier disruption (a hallmark of dry eye);28 we investigated the effect of aging in aged female B6 mice. APCs are master regulators of immune responses and receive signals from the microenvironment to prime naïve CD4+T cells into different subsets of Th cells. We sought to investigate the phenotype and activation markers of APCs in the conjunctiva and cervical lymph nodes (CLNs) of young and aged female mice. Aging has been shown to affect the function and phenotype of dendritic cells.30,31
Evaluation of whole mount palpebral conjunctivae from 8-week-old (young) and 24-month-old (aged) B6 female mice by laser scanning confocal microscopy demonstrated an increase in epithelial CD11c+ and CD11b+ cells (Fig. 1a). We quantified intraepithelial APCs by counting CD11c+, CD11b+ and MHC II+ positive cells that were present among epithelial cells or immediately below the basal membrane in palpebral conjunctival cryosections.20,32 There was a significant increase in the frequency of intraepithelial CD11b+, CD11c+ and MHC II+ cells in the palpebral conjunctiva of aged mice (Fig. 1b, c).
Accumulation of dendritic cells in peripheral tissues is an age-related phenotype30 which is still poorly understood. To investigate if there was a gradient of chemokines that could be recruiting APCs from the circulation, we performed real-time PCR analysis for CCL2, CCL3, CCL4, CCL22, and CXCL13 chemokines in samples obtained from whole thickness conjunctival biopsies. CCL2, CCL3, and CCL4, CCL22 are potent monocytes/macrophages chemoattractants.33,34 CXCL13 is a B-cell chemoattractant, but it has been shown to be highly produced by aged CD11c+CD11b+ cells.35,36 There was no change in the mRNA levels of CCL2, CCL3, and CCL4 while there was a 3-fold increase in CXCL13 levels in the aged conjunctiva, which was accompanied by a decrease in CCL22 chemokine (Fig. 1d). These results indicate that some other factors yet to be determined are responsible for retaining APCs in the aged conjunctiva.
Since CD11c+MHC II+ cells can be further divided into CD103+ or CD11b+ cells,37 we then performed flow cytometry analysis in conjunctival and nodes including these markers (Fig. 2a, b). We observed increased CD86 expression in conjunctival MHC II+CD11c+CD11b+ CD103− cells from aged mice, while there was a decrease in CD86 expression in MHC II+CD11c+CD11b−CD103+ and MHC II+CD11c+CD11b+CD103− cells at the nodes compared to the young group (Fig. 2c, d). No change in CD86 expression was observed in the macrophage population with aging neither at the ocular surface nor the draining nodes.
Inflammation has been described as a characteristic of aging.38 To investigate this, we performed real-time PCR in full thickness biopsies of the conjunctiva of young and aged mice. Increased IL-1β, MHC II, IL-12, and IFN-γ mRNA levels were present in aged compared to young conjunctivas (Fig. 2e). Increased immunoreactivity to IL-1β was observed in palpebral conjunctival sections at the basal layer of the conjunctiva in aged mice, while minimal reactivity was seen in young conjunctivas (Fig. 2f). IL-12+ cells were also easily identified in the same area of aged mice. To confirm the increased levels of IFN-γ, we performed flow cytometry using conjunctival suspensions. There was a significant increase in the frequency and MFI of CD45+ IFN-γ+ cells in the conjunctiva of aged mice (Fig. 2g, h).
These results indicate that an aged conjunctival mucosa is a pro-inflammatory microenvironment that retains more APCs or APC precursors and drives their semi-maturation before migration to the draining CLN.
RA activity in aging in the conjunctiva
Ahadome and colleagues were the first to describe aldehyde dehydrogenases (ALDH)-expressing/retinoic acid (RA)-producing dendritic cells in the conjunctiva.39 Our group has also shown conjunctival goblet cells produce biologically active RA that suppresses CD86 expression and IL-12 production by myeloid cells.24 The ability to convert retinol (vitamin A) into the immunosuppressive metabolite RA depends on orchestrated sequential conversions by alcohol dehydrogenases and ALDH. Expression analysis of aldehyde dehydrogenase family 1, subfamily A2 (aldh1a2) isoform gene that is found in APCs, showed a significant decrease in the aged conjunctiva (Fig. 2i). Because greater RA synthesizing activity correlates with immune tolerance in skin and gut,40,42,43,43 we investigated ALDH activity on a per-cell basis in live single cell suspensions from young and aged conjunctiva. There was a significant decrease in total ALDH activity in conjunctival suspensions from aged mice (Fig. 2i).
These results indicate that RA conversion by APC and epithelial cells in the ocular surface microenvironment24 may be critical for maintaining local immune tolerance and it is decreased in aged mice. In addition to the intestinal tract, the ocular surface is another mucosal site where RA-producing APCs are very abundant.
Higher uptake of antigens by aged APCs
To determine the migration of antigen-loaded APCs to draining lymph nodes, we topically applied FITC-conjugated OVA peptide 30 min before euthanasia. The OVA peptide has a much smaller molecular weight than full OVA (2.3 kDa vs. 45 kDa), and we have previously shown the migration of antigens topically applied to the ocular surface into the conjunctival stroma decreases with increasing molecular weight.44 Using laser confocal microscopy of whole mount conjunctiva, we confirmed our previous observation of increased diffusion of OVA peptide through goblet cell-associated passages (Fig. 3a).44 Compared to young mice, a greater frequency of OVA+CD11c+ and OVA+ CD11b+ cells and increased free OVA peptide in the stroma were readily observed in the aged conjunctiva (Fig. 3a).
Next, we performed flow cytometry on cell suspensions from conjunctivas and draining nodes of eyes that had been topically dosed with fluorescent OVA peptide or vehicle control twice (at 0 and 12 h before harvesting conjunctiva and CLN at 24 h). A greater frequency of OVA peptide+MHC II+CD11b+CD11c+ cells was observed in aged than young conjunctiva 24 h post application. Similar results were seen in draining lymph nodes, although at much smaller percentages than conjunctiva (Fig. 3b, c), demonstrating both increased uptake by ocular surface APCs and increased migration of antigen-loaded APCs to draining nodes in aged mice. Increased frequency of CD11b+F4/80+OVA peptide+ cells was seen only in the aged CLN (Fig. 3b, c).
Because we saw an increased diffusion of surrogate antigens, we sought to investigate the expression of the tight junction protein occludin as a surrogate of barrier function. Occludin is one of the tight junction proteins that is expressed in apical corneal cells.45,49,50,48 To asses this, we obtained whole mounts of corneas and conjunctivas from both age groups and stained with an anti-occludin antibody, as previously described.48 We also measured the apical cell area using imaging analysis software, since a smaller apical cell area is a characteristic of dry eye corneas.48 We observed an increased frequency of desquamating cells in aged corneas (Fig. 3d, arrows). No evident loss of tight junction protein occludin was seen in aged corneas, although there was greater cytoplasmic staining compared to young corneas (Fig. 3d). There was a marked decrease in apical cell area (2070 ± 411 vs. 1298 ± 395.5 μm2; young vs. aged, respectively, P = 0.0012, n = 4 corneas). In the bulbar conjunctiva, loss of tight junction occludin immunoreactivity was evident in aged mice (Fig. 3d). Compared to young group, apical cell surface area was also significantly decreased in the aged bulbar conjunctiva (1658 ± 245 vs. 1015 ± 137 μm2; young vs. aged, respectively, P = 0.02, n = 4 conjunctivas).
These results suggest that the combination of increased permeability of surrogate antigens through a leaky epithelium or increased internalization of antigen by APCs contributes to the higher recovery of antigen laden APCs in the aged lymph nodes.
Aged APCs prime Th-1 cells
To assess the ability of young and aged APCs to stimulate CD4+ T cells, single cell suspensions from CLN were prepared, pulsed with OVA323–339 peptide and mixed with isolated OVA-specific OT-II CD4+T cells as described in the methods. Our pilot studies demonstrated that about 93% of CLN CD11c+ cells are MHC II+ (data not shown). Proliferation and frequency of CD4+Foxp3+, CD4+IFN-γ+ (Th-1), and CD4+IL-17+ (Th-17) cells and cytokine concentrations in culture supernatants were used as endpoints of T cell priming. Cells and supernatants were collected after 3–4 days of co-culture. Full cell suspensions of OT-II splenocytes that contained both CD4+ and APC cells pulsed with OVA323–339 peptide were used as positive controls for kinetic studies. Analysis of proliferating OT-II cells demonstrated that aged CLN APCs induced greater T cell proliferation compared to young APCs (Fig. 4a). This was accompanied by an increased frequency and number of Th-1 cells (Fig. 4b–d) and increased IFN-γ concentration in culture supernatants from the aged group (Fig. 4e). No changes in frequency or number of Th-17 cells were observed between the young and aged group (Fig. 4).
Increased frequency of Th-1 cells in aged ocular tissues
Based on our observations that aged APCs primed Th-1 cells (Fig. 4), we then asked if mice have increased Th-1 frequency in ocular tissues as they age. Because IL-17 has been implicated in dry eye,15,17,20,21,22,49,53,54,52 we also investigated Th-17 cell frequencies in aged ocular tissues. To address this, we prepared single cell suspensions from LG, and CLN from young and aged female B6 mice and performed intracellular staining for IFN-γ and IL-17. Our results shown in Fig. 5 demonstrated that Th-1 cell frequency increased with aging (Fig. 5a, b) in both LG and CLN, while only a systemic increase was seen for Th-17 cells (CLN). Aging was accompanied by an increase in CD4−IFN-γ+ cells (LG: 7.2 ± 4 vs. 16.05 ± 7%, young vs. aged, respectively, P < 0.01; CLN: 0.64 ± 0.25 vs. 12.60 ± 7.7%, young vs. aged, respectively, P < 0.001). An increased Th-1/Th-17 ratio was present in aged LG and CLN, demonstrating that the predominant Th response in aged female B6 mice is Th-1 biased (Fig. 5c).
Because Th-1 cells and Th-17 cells can be isolated based on their CXCR3 or CCR6 chemokine expression (respectively53,57,55) we investigated the frequency of CD4+CXCR3+IFN-γ+ or CD4+CCR6+IL-17+ cells in the conjunctiva, CLN and LGs of young and aged mice. Similarly to the frequency of Th-1 cells, there was a significant increase in the frequency of IFN-γ producing CD4+CXCR3+ cells in these three tissues in the aged group (Fig. 5d, e). An increased frequency of IL-17A-producing CD4+CCR6+ cells was only identified in the aged CLN (Fig. 5d, e).
Increased pathogenicity of aged Th-1 cells
We have previously shown that IFN-γ participates in age-associated ocular surface disease by demonstrating that IFN-γ knock-out (KO) mice were partially resistant to age-related conjunctival goblet cell loss.28 To investigate if the increased frequency of Th-1 cells in aged mice would correlate with increased pathogenicity to the ocular surface, we performed adoptive transfer experiments of Th-1 cells. We have previously shown that adoptively transferred cells from dry eye or aged mice migrate back to the ocular surface and LGs of recipient mice27,56,57 and increased levels of IFN-γ were present in the conjunctiva of recipients.21 Using this experimental design, we isolated CD4+CXCR3+ cells from CLN and spleens of young and aged B6 mice using a two-step magnetic isolation protocol. Isolated cells were either lysed for RNA analysis or adoptively transferred into young female RAG1KO hosts. In the adoptive transfer experiments, bulk, unfractionated CD4+ T cells were isolated and adoptively transferred as comparator groups. Gene expression analysis of isolated cells confirmed higher levels of IFN-γ mRNA in CD4+CXCR3+ cells (aged > young, P < 0.0001) with negligible amounts of IL-17A compared to CD4+CXCR3− cells (Fig. 6a).
Evidence of dry eye disease was investigated five weeks post-transfer. We used goblet cell density as an endpoint since goblet cells are susceptible to the deleterious effects of IFN-γ (decrease in number, decrease in mucin production and a decrease in calcium release upon agonist stimulation)20,21,22,23,28,58 and because goblet cell loss is universally seen in the aqueous-deficient dry eye.59,60 As shown in Fig. 6 b, c, adoptive transfer of aged T cells induced a significant decrease in mucin-filled goblet cells in RAG1KO recipients compared to young donors; however, this effect was strikingly accentuated in young RAG1KO that received aged CD4+CXCR3+ cells. Lymphocytic infiltration in LG of recipients of aged CD4+CXCR3+ cells was also observed (Fig. 6c). Taken together, these results indicate that a pathogenic role for Th-1 cells in age-related dry eye disease.
Discussion
Aging is a risk factor for dry eye.2 Our published studies demonstrated that IFN-γ is critical for age-associated conjunctival goblet cell loss as IFN-γKO mice were partially resistant to age effects.28 Here we showed that aging is accompanied by significant changes in APC phenotype and function and also by increased frequency of pathogenic Th-1 cells.
Aged B6 mice showed an altered distribution of APCs in the conjunctiva, with greater accumulation of these cells in the epithelial cell layer. These conjunctival APCs also displayed greater CD86 expression. It has been shown that goblet cells secrete immunomodulatory factors such as TGF-β and retinoic acid24,25,26 and that mice devoid of goblet cells have an altered distribution of conjunctival APCs.61 It is possible that age-related goblet cell loss seen in aged B6 mice27 may contribute to the altered distribution and increased activation markers seen in our study, and these findings warrant further investigation.
Our results showed increased inflammation in aged conjunctiva compared to young controls. We observed an increased frequency of MHC II+ cells, increased IFN-γ, IL-12, IL-1β mRNA and protein levels and elevated CXCL13 mRNA transcripts. While there is no question that the aged conjunctiva is an inflammatory site, it is unclear if this pro-inflammatory microenvironment is a cause or consequence of the accumulation of APCs with aging. In support of the latter, it has been shown that aged dendritic cells have a semi-mature state at baseline and supernatants from dendritic cells from aged subjects activated epithelial cells to produce cytokines in the absence of bacterial stimuli while supernatants from young subjects did not have the same effect.62 However, further studies are necessary to dissect the individual contribution to epithelial and APCs; it is possible that this crosstalk is bi-directional.
Our results showed that conjunctival suspensions from aged mice had lower ALDH activity than young. ALDH is responsible for the last step in the conversion of vitamin A (retinol) into its active metabolite retinoic acid. Our results agree with Ahadome and colleagues who were the first to describe that RA-producing dendritic cells are present in conjunctiva.39 We have previously shown that aged mice have greater than 50% conjunctival goblet loss at 24 months of age.27 A decrease in goblet cells is an essential part of the dry eye phenotype since our in vitro studies showed that conjunctival goblet cells secrete bioactive RA that can modulate dendritic cell activation markers.24 Inflammatory stimuli, such as zymosan and LPS, have been shown to increase ALDH activity.63 Despite a pro-inflammatory environment (evidenced by elevated levels of IL-12, IL-1β, and IFN-γ in the conjunctiva), our results showed that aged APCs failed to upregulate ALDH activity as a compensatory mechanism, maybe due to conjunctival goblet cell loss.27 Reduced RA conversion in the eye microenvironment suggests a defect in immune tolerance mechanisms that accompany aging. Supporting our hypothesis, Pinkie mice, which have a 90% loss of RXRα activity secondary to a mutation of the mouse retinoid X receptor α, have increased Th-1 polarization in vitro with aging and decreased suppressive activity by their Tregs.64 Therefore, the combined low expression of Aldh1a2 gene in the conjunctiva and the failure to increase ALDH activity in an inflammatory milieu may favor disruption of mucosal tolerance.
We have previously shown that in mice devoid of goblet cells, there is an accumulation of dendritic cells and macrophages at the ocular surface and altered surrogate antigen distribution after topical instillation.44 Greater recovery of a topically applied surrogate antigen (OVA peptide) was observed in the conjunctiva and draining lymph nodes of aged mice in this study. Our z-stack laser confocal images showed increased free OVA peptide in the conjunctiva of aged compared to young mice. It is possible that greater diffusion of OVA peptide into the epithelium due to inflammation-associated barrier dysfunction could increase the availability of surrogate antigens. Our studies evaluating occludin staining in whole mounts of cornea and bulbar conjunctiva showed a decrease in apical cell area in aged cornea and bulbar conjunctiva, indicating that the apical and larger cells might have already desquamated. This is well observed in experimental dry eye in mice subjected the desiccating stress.48 Furthermore, discontinuity of the tight junctions in aged conjunctiva may explain the increased availability of antigens to resident APCs which are now free to migrate to the regional lymph nodes.
It has been demonstrated that IFN-γ is pathogenic to the ocular surface and LG acinar epithelial cells,16,20,21,22 two different cell types that are negatively impacted by aging.27,28 Our results indicate that aging is accompanied by increased frequency of Th-1 cells not only in the draining nodes but also in LGs. Although Th-1 and Th-17 cells are readily observed in young mice subjected to desiccation,17,49,65 we did not observe an age-related increase in Th-17 in LG or conjunctiva; only in draining lymph nodes. We have previously shown that adoptively transferred cells from dry eye or aged mice migrate back to the ocular surface and LGs of recipient mice27,56,57 and increased levels of IFN-γ are present in the conjunctiva of recipients.21 We have extensively shown that IFN-γ is deleterious to the ocular surface: (1) IFN-γKO mice are resistant to desiccation-induced goblet cells loss but subcutaneous administration of IFN-γ into IFN-γKO mice leads to goblet cells loss, recapitulating the wild-type phenotype;20 (2) IFN-γ antibody depletion in wild-type mice during desiccating stress improves goblet cell loss;21 (3) addition of IFN-γ to conjunctiva goblet cell cultures lead to cell death and loss of mucin production;22 (4) 15-month old IFN-γKO mice have greater number of goblet cells than age-matched wild-type mice.28 The results of our adoptive transfer experiments support our hypothesis that aged Th-1 cells are pathogenic to the ocular surface since recipients of aged CXCR3+ cells had the greatest goblet cell loss compared to recipients of aged bulk CD4+ and young CD4+CXCR3+ donors. These experiments highlight that loss of mucosal immune tolerance with aging leads to a spontaneous generation of eye-pathogenic T cells since our experiments did not use any immunization protocols nor autoimmune mice.
Our new findings implicate increased APC maturation and generation of pathogenic Th-1 cells in the pathogenesis of age-associated dry eye. Further studies are needed to dissect if alterations in the ocular microenvironment are the cause or consequence of age-related dry eye disease.
Materials and methods
Animals
Breeder pairs of C57BL/6J (B6), recombination activating protein one knock-out (RAG1KO) and B6.Cg-Tg (TcraTcrb) 425Cbn/J (OT-II) mice 6-8 weeks old were purchased from The Jackson Laboratory (Bar Harbor, ME) for establishing breeder colonies. Naturally aged female B6 mice were maintained in specificfree pathogen vivarium and were used at 24 months of age. Only mice free of visible tumors were used. RAG1KO (n = twelve) and OT-II (n = eighteen) mice were used at 6–10 weeks of age. The Institutional Animal Care and Use Committees at Baylor College of Medicine approved all animal experiments. All studies adhered to the Association for Research in Vision and Ophthalmology statement for the Use of Animals in Ophthalmic and Vision Research and to the National Institutes of Health guide for the care and use of Laboratory Animals (NIH Publications No. 8023, revised 1978). One-hundred and twenty-two B6 female mice per age were used. All efforts were made to collect more than one tissue from the same mouse whenever possible. An exact sample size per test is displayed in the figure legends.
Flow cytometry analysis
Conjunctivas and lacrimal glands were excised and incubated with 0.1% Collagenase IV as previously described.44 Draining nodes were excised and prepared as previously described.66 Single cell suspensions were incubated with anti-CD16/32 (4 °C, 10 min), and subsequently stained using different panels. For the APC panel, cells were stained with CD45_BV510 (clone 30F11, BD Biosciences), CD11c_FITC (Clone HL3, BD Pharmingen, San Diego, CA), CD86_Pacific Blue (clone GL-1, BD Pharmingen), MHC II_PE (clone I-A/I-E, BD Pharmingen), anti-CD103_APC (clone 2E7, Biolegend, San Diego, CA), F4/80_PE-CY5 (clone BM8, ebiosciences/Thermofisher,Waltham, MA), CD11b_PE-Cy7 (clone M1/70, BD Biosciences) antibodies and infra-red lived/dead Fixable Dead Cell Stain™ (Life Technologies, Grand Island, NY). Cells were kept on ice until analysis on a FACS Canto II System. The gating strategy was: lymphocytes were identified by forward, and side scatter properties, single cells were identified, dead cells were excluded, and CD45+ cells were identified. CD11c+ cells were then plotted versus MHC II and further gated into CD103+ or CD11b+cells.37 MHC II+CD11c− cells were identified and plotted versus F4/80 and CD11b to gate MHC II+CD11b+F4/80+ cells. Median fluorescence intensity (MFI) of CD86 staining was then analyzed in these populations.
For intracellular cytokine staining, single cell suspensions were obtained and 106 cells were incubated for five hours in the presence of 5% CO2 with 0.5 µL Golgi Stop™ (BD Bioscience), 0.5 µL Golgi Plug™ (BD Bioscience), PMA (0.5 µg) (Sigma-Aldrich, St. Louis, MO), ionomycin (0.5 µg) (Sigma) in 1 mL in complete RPMI 1640. Cells were stained with an infra-red fluorescent reactive dye (Life Technologies, Grand Island, NY) before incubation with a Foxp3 Fixation/Permeabilization working solution (eBioscience) for 18 h as previously described.67 The following antibodies were used: CD4_FITC (clone GK1.5, BD Bioscience), IL-17_PE (clone eBio17B7, eBioscience), Foxp3_APC (clone FJK-16S, eBioscience), IFN-γ_Pacific Blue (clone XMG1.2, Biolegend), CD45_Alexa Fluor®700 (clone 30F11, Biolegend). The gating strategy was: dead cells were excluded by gating live fixable blue dye versus CD45+ cells, and two singlet gates were made. CD4+ T cells were gated and frequency of CD4+Foxp3+ cells and CD4+IFN-γ+ and CD4+IL-17A+ calculated among CD4+ T cells. In some experiments, collagenase-digested LGs, conjunctiva, and CLN were stained with CD4_FITC, and CXCR3_PE antibodies (clone 220803, R&D Systems, Minneapolis, MN) and intracellular staining for IFN-γ or IL-17 was performed as above.67 Negative controls consisted of fluorescence minus one (FMO) splenocytes.
Cells were acquired with either BD LSR II or BD Canto II Benchtop cytometer with BD Diva software version 6.7 (BD Biosciences). At least 100,000 events or more were collected. Final data were analyzed using FlowJo software version 10 (Tree Star Inc., Ashland, OR).
RNA isolation and Real-time PCR
Total RNA from isolated cells or conjunctiva (both eyes pooled) was extracted using a QIAGEN RNeasy Plus Micro RNA isolation kit (Qiagen) following the manufacturer’s protocol. Five mice per age were pooled, and cells were isolated. One sample equaled a number of remaining cells after isolation. After isolation, the concentration of RNA was measured, and cDNA was synthesized using the Ready-To-Go™ You-Prime First-Strand kit (GE Healthcare). Real-time PCR was performed using specific MGB Taqman probes for IL-1β (Il1b, Mm00434228), IL-12a (IL-12a, Mm00434165), major histocompatibility complex class II (MHC-II, Mm00482914), aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2, Mm00501306), IFN-γ (Ifng, Mm00801778), C-C motif chemokine ligand 2 (Ccl2, Mm00441242), C-C motif chemokine ligand 3 (Ccl3, Mm00441258), C-C motif chemokine ligand 4 (Ccl4, Mm00443111), C-C motif chemokine ligand 22 (Ccl22, Mm00436439), C-X-C motif chemokine ligand 13 (Cxcl13, Mm00444533), C-X3-C motif chemokine ligand 1 (Cx3cl1, Mm00436454) (Taqman Universal PCR Master Mix AmpErase UNG) in a commercial thermocycling system (StepOnePlus™ Real-Time PCR System, Applied Biosystems), according to the manufacturer’s recommendations. The hypoxanthine phosphoribosyltransferase 1 (HPRT1, Mm00446968) gene was used as an endogenous reference for each reaction. The results of quantitative PCR were analyzed by the comparative Ct method and were normalized by the Ct value of HPRT1.68 The young group served as calibrator.
Histology, PAS staining, and IHC
Eyes and ocular adnexa were excised, fixed in 10% formalin, paraffin embedded and were cut into 5-µm sections using a microtome (Microm HM 340E, Thermoscientific Wilmington, DE USA). Sections cut from paraffin-embedded globes were stained with Periodic Acid Schiff (PAS) reagent. The goblet cell density was measured in the superior and inferior bulbar and tarsal conjunctiva using NIS-Elements software and expressed as the number of positive cells per millimeter per eyelid.20
Immunohistochemistry was performed to detect CD11b, CD11c and MHC II cells in the conjunctiva using CD11b (1:100, clone M1/70, BD Biosciences, San Diego, CA), CD11c (1:100, clone HL3, BD Biosciences) and MHC II (1:100, I-A/I-E, Clone M5/114.15.2, BD Pharmingen, San Diego, CA) or IL-1β (1:50, clone D4T2D; Cell Signaling Technology, Danvers, MA) antibodies and appropriate biotinylated secondary antibodies (BD Biosciences) and a Vectastain Elite ABC kit using NovaRed reagents (Vector Laboratories, Burlingame, CA) as previously described.20,69 CD11c+ and CD11b+ cells were counted in the epithelium in three sections taken from five to six different animals of each age that were examined and photographed under 10X magnification with a microscope equipped with a digital camera (Eclipse E400 with a DS-Fi1; Nikon). Individual cells located within the epithelium or immediately below the epithelial basement membrane were counted as positive using image-analysis software (NIS Elements Software, version 3.0, BR). The immunoreactivity to IL-1 β was diffuse, and it did not allow for counting individual cells.
Immunofluorescence was performed to detect IL-12 using an IL-12-PE-conjugated antibody (1:100, clone C15.6, 1:100 dilution, BD Pharmingen) using cold acetone fixation and 20% goat serum as blocking solution.
Aldehyde dehydrogenase activity
The presence of cells with aldehyde dehydrogenase activity (ALDHbright) was assessed using the Aldefluor staining kit (StemCell Technologies, Cambridge, MA) following the manufacturer’s protocol. Single cell suspensions from either conjunctiva or CLN were incubated in the dark for 1 h at 37 °C in Aldefluor assay buffer containing activated Aldefluor substrate, with or without the ALDH inhibitor, diethylaminobenzaldheyde (DEAB) in ice-cold Aldefluor assay buffer, resuspended in Aldefluor assay buffer containing propidium iodide, and kept on ice until immediate analysis on a FACS Canto II System. Data were analyzed using FlowJo software version 10 (TreeStar Inc., Ashland, OR). For each sample, the total percentage of positive cells was calculated after subtraction of test tube results from control results (cells stained with DEAB). After live/dead staining and singlet discrimination, aldefluor positive cells were gated and analyzed.
Laser scanning confocal scanning microscopy
Freshly harvested whole-mount conjunctivas, with or without pre-application of a 2.5 μl eye drop of FITC conjugated OVA peptide (OVAp, 5 mg/mL, KareBay Biochem Inc, Monmouth Junction, NJ), to the ocular surface, were fixed in cold methanol and later stained as described using anti-CD11c and anti-CD11b (clone HL3, and clone M1/70, respectively, BD Biosciences, San Diego, CA) antibodies.44
Whole mounts of cornea and conjunctiva from young and aged mice (n = 3 mice/group) were surgically prepared and fixed with cold methanol and stained with occludin (Zymed, San Francisco, CA) and Alexa Fluor® 488-conjugated goat anti-rabbit antibody. The images were processed using NIS Elements 4.20 version (Nikon).
Digital confocal images were captured with a laser scanning confocal microscope (Nikon A1 RMP, Nikon, Melville, NY) wavelength 400–750 nm and one µm z-step. The images were processed using NIS Elements 4.20 version (Nikon, Garden City, NY).
Apical cell area in occludin-stained whole mounts was measured in digital images using NIS Elements as previously described.48 At least 5-8 cells per image were randomly measured by a masked observer.
Recovery of topically applied antigens at draining nodes
A topical dose of 2.5 μl of FITC labeled OVA323-339 peptide (OVAp, 5 mg/mL, KareBay Biochem Inc, Monmouth Junction, NJ) was topically instilled in each eye of young and aged mice at times 0 and 12 hrs and the animals were euthanized 12 hrs after the second dose (24 hrs total) and compared to mice that received vehicle dosing (water). Conjunctivas were excised and incubated with 0.1% collagenase and prepared for flow cytometry using anti-CD16/32, followed by staining with anti-CD45_BV510, anti-MHC II_PE, anti-CD11c_APC, and anti-CD11b_PE-Cy7 antibodies. Live cells were suspended in PBS/1% FBS containing 1 μL of violet LIVE/DEAD Fixable Dead Cell Stain™ (Life Technologies, Grand Island, NY) washed, and kept on ice until flow cytometry analysis. Cells were analyzed with BD Canto II Benchtop cytometer with BD Diva software version 6.7 (BD Biosciences). Final data were analyzed using FlowJo software version 10 (Tree Star Inc., Ashland, OR). Fluorescent minus one controls were used for setting up the gates. The following gating strategy was used in this study: cells were gated by FSC-A (FSC-A) versus SSC-A then sequentially gated into single cells twice (FSC-A vs. height and then SSC-A vs. SS-height). Dead cells were excluded by gating alive CD45+ cells. CD11c cells were then plotted with MHC II and further gated into CD11b+cells.37 CD11c- MHC II+cells were gated with the expression of CD11b+ F4/80+ cells. The frequency of OVA+ cells was then calculated in both populations.
Cell proliferation assay
Cervical lymph node suspensions from young and aged B6 mice were prepared and plated at 1.0 × 105/100 µl (WST) or 5 × 105/500 µl (flow cytometry) per well and pulsed with OVA323-339 peptide (10 μg/ml, InvivoGen, San Diego, CA) for 1 h. CD4+ T cells were isolated from spleens of OT-II mice using the untouched CD4+ T cell isolation kit according to the manufacturer’s instructions (Miltenyi Biotec, Auburn, CA) and plated at 0.5 × 106 in 100 µl (WST) or 500 µl (flow cytometry) per well in 96-well plates and incubated for 3–4 days. The CD4 enriched cell suspensions contained greater than 93% CD4+T cells as determined by flow cytometry (data not shown). Cells were used for flow cytometry, while supernatant media was collected and stored at −80 °C until use. In some experiments, cell proliferation was measured by applying the WST-1 reagent (Roche) 24 h after plating and measured up to 48 h later.
Multiplex cytokine immunobead assay (Luminex)
Culture assay supernatants were collected, and Luminex assay determined cytokine production. Samples were added to wells containing the appropriate cytokine bead mixture that included mouse monoclonal antibodies specific for IFN-γ, IL-17 (Upstate-Millipore, Billerica, MA) as previously reported.57 The reactions were detected with streptavidin-phycoerythrin using a Luminex 100 IS 2.3 system (Austin, TX, USA). The limit of detection for this assay was 3.4 pg/ml for IFN-γ, and 3.19 pg/ml for IL-17.
Adoptive transfer experiments
Bulk CD4+ T cells were isolated from spleens and CLN from young and aged B6 mice using magnetic beads according to the manufacturer’s instructions (untouched CD4+ T cell isolation kit, Miltenyi Biotec, Auburn, CA). The CD4 enriched cell suspensions contained ≥90% CD4+ T cells as determined by flow cytometry (data not shown).
CD4+CXCR3+ cells were isolated from the spleens and CLN from young and aged B6 mice via a two-step procedure in which CD4+ T cells were pre-enriched by depletion of unwanted cells using the kit described above. The CD4+ T cell fraction was then incubated with the anti-CXCR3_PE antibody (R&D Systems, Minneapolis, MN) and then magnetically labeled with anti_PE microbeads and positively selected for CD4+CXCR3+ cells, according to the manufacturers’ instructions (Miltenyi Biotec, Auburn, CA). These cells were used to perform adoptive transfer experiments or collected for quantitative gene expression. Young and aged bulk CD4+T or CD4+CXCR3+ cells (2 × 106) were transferred intraperitoneally (i.p.) into 6–10 week old T cell deficient RAG1KO mice. Experiments were performed five weeks after adoptive transfer of bulk CD4+T cells or CD4+CXCR3+ cells. Eyes were collected for goblet cell density analysis and LGs were collected for histology.
Statistical analysis
The sample size was calculated with StatMate Software (GraphPad Software, La Jolla California USA) based on pilot studies. Statistical analyses were performed with Graph Pad Prism software (GraphPad Software, La Jolla California USA, version 7). Data were first evaluated for normality with the Kolmogorov-Smirnov normality test. Appropriate parametric (t-test) or non-parametric (Mann–Whitney) statistical tests were used to make comparisons between two age groups. Whenever adequate, one-way ANOVA followed by Sidak’s post hoc test was used. All experiments were repeated at least once. The final sample per experiment is shown in figure legends.
References
Schein, O. D. et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch. Intern. Med. 159, 1359–1363 (1999).
Schaumberg, D. A., Sullivan, D. A., Buring, J. E. & Dana, M. R. Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 136, 318–326 (2003).
Chotikavanich, S. et al. Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome. Invest. Ophthalmol. Vis. Sci. 50, 3203–3209 (2009).
Franceschi, C. et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY. Acad. Sci. 908, 244–254 (2000).
Carrieri, G. et al. The G/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell. 3, 443–448 (2004).
Bruunsgaard, H. et al. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin. ExpImmunol. 132, 24–31 (2003).
Franceschi, C. et al. The network and the remodeling theories of aging: historical background and new perspectives. Exp. Gerontol. 35, 879–896 (2000).
Schaumburg, C. S. et al. Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J. Immunol. 187, 3653–3662 (2011).
Baudouin, C., Brignole, F., Pisella, P. J., De Jean, M. S. & Goguel, A. Flow cytometric analysis of the inflammatory marker HLA DR in dry eye syndrome: results from 12 months of randomized treatment with topical cyclosporin A. Adv. Exp. Med. Biol. 506(Pt B), 761–769 (2002).
Brignole, F. et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. Invest. Ophthalmol. Vis. Sci. 42, 90–95 (2001).
Epstein, S. P., Gadaria-Rathod, N., Wei, Y., Maguire, M. G. & Asbell, P. A. HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease. Exp. Eye Res. 111, 95–104 (2013).
Yang, S. et al. Interferon-gamma-induced intestinal epithelial barrier dysfunction by NF-kappaB/HIF-1alpha pathway. J. Interferon Cytokine Res. 34, 195–203 (2014).
Beaurepaire, C., Smyth, D. & McKay, D. M. Interferon-gamma regulation of intestinal epithelial permeability. J. Interferon Cytokine Res. 29, 133–144 (2009).
Lam, H. et al. Tear Cytokine Profiles in Dysfunctional Tear Syndrome. Am. J. Ophthalmol. 147, 198–205 (2009).
Pflugfelder, S. C. et al. Aqueous tear deficiency increases conjunctival interferon-γ (IFN-γ) expression and goblet cell loss. Invest. Ophthalmol. Vis. Sci. 56, 7545–7550 (2015).
Tsubota, K. et al. Regulation of human leukocyte antigen expression in human conjunctival epithelium. Invest. Ophthalmol. Vis. Sci. 40, 28–34 (1999).
Chen Y., et al. IFN-gamma-Expressing Th17 Cells Are Required for Development of Severe Ocular Surface Autoimmunity. J. Immunol. 199, 1163–1169 (2017).
Pelegrino, F. S. et al. Deletion of interferon-gamma delays onset and severity of dacryoadenitis in CD25KO mice. Arthritis Res. Ther. 14, R234 (2012).
Cha, S. et al. A dual role for interferon-gamma in the pathogenesis of Sjogren’s syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60, 552–565 (2004).
de Paiva, C. S. et al. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ. Invest. Ophthalmol. Vis. Sci. 48, 2553–2560 (2007).
Zhang, X. et al. Topical interferon-gamma neutralization prevents conjunctival goblet cell loss in experimental murine dry eye. Exp. Eye Res. 118, 117–124 (2014).
Coursey, T. G., Henriksson, J. T., Barbosa, F. L., de Paiva, C. S. & Pflugfelder, S. C. Interferon-gamma-induced unfolded protein response in conjunctival goblet cells as a cause of mucin deficiency in Sjogren syndrome. Am. J. Pathol. 186, 1547–1558 (2016).
Garcia-Posadas, L. et al. Interaction of IFN-gamma with cholinergic agonists to modulate rat and human goblet cell function. Mucosal Immunol. 9, 206–217 (2016).
Xiao, Y., et al. Goblet cell produced retinoic acid suppresses CD86 expression and IL-12 production in bone marrow derived cells. Int. Immunol. 30, 457–470 (2018).
Contreras-Ruiz, L. & Masli, S. Immunomodulatory cross-talk between conjunctival goblet cells and dendritic cells. PLoS ONE 10, e0120284 (2015).
Contreras-Ruiz, L., Ghosh-Mitra, A., Shatos, M. A., Dartt, D. A. & Masli, S. Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediat. Inflamm. 2013, 636812 (2013).
McClellan, A. J. et al. Ocular surface disease and dacryoadenitis in aging C57BL/6 mice. Am. J. Pathol. 184, 631–643 (2014).
Volpe, E. A. et al. Interferon-gamma deficiency protects against aging-related goblet cell loss. Oncotarget. 7, 64605–66461 (2016).
Moss, S. E., Klein, R. & Klein, B. E. Prevalence of and risk factors for dry eye syndrome. Arch. Ophthalmol. 118, 1264–1268 (2000).
Stichel, C. C. & Luebbert, H. Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol. Aging. 28, 1507–1521 (2007).
Agrawal, A. & Gupta, S. Impact of aging on dendritic cell functions in humans. Ageing. Res. Rev. 10, 336–345 (2011).
Zhang, X. et al. NK cells promote Th-17 mediated corneal barrier disruption in dry eye. PLoS ONE 7, e36822 (2012).
Endlich, B., Armstrong, D., Brodsky, J., Novotny, M. & Hamilton, T. A. Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury. J. Immunol. 168, 3586–3594 (2002).
Mariani, E. et al. RANTES and MIP-1alpha production by T lymphocytes, monocytes and NK cells from nonagenarian subjects. Exp. Gerontol. 37, 219–226 (2002).
Ishikawa, S. et al. Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b + CD11c + dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC. J. Exp. Med. 193, 1393–1402 (2001).
Ishikawa, S. et al. Increased circulating CD11b + CD11c + dendritic cells (DC) in aged BWF1 mice which can be matured by TNF-alpha into BLC/CXCL13-producing DC. Eur. J. Immunol. 32, 1881–1887 (2002).
Khandelwal, P. et al. Ocular mucosal CD11b + and CD103 + mouse dendritic cells under normal conditions and in allergic immune responses. PLoS ONE 8, e64193 (2013).
Franceschi, C. & Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A. Biol. Sci. Med. Sci. 69(Suppl 1), S4–S9 (2014).
Ahadome S. D., et al. Classical dendritic cells mediate fibrosis directly via the retinoic acid pathway in severe eye allergy. JCI Insight. 1, e87012 (2016).
Guilliams, M. et al. Skin-draining lymph nodes contain dermis-derived CD103(-) dendritic cells that constitutively produce retinoic acid and induce Foxp3( + ) regulatory T cells. Blood 115, 1958–1968 (2010).
Coombes, J. L. & Powrie, F. Dendritic cells in intestinal immune regulation. Nat. RevImmunol. 8, 435–446 (2008).
Coombes, J. L. et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3 + regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764 (2007).
Belkaid, Y. & Oldenhove, G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29, 362–371 (2008).
Barbosa, F. L. et al. Goblet cells contribute to ocular surface immune tolerance-implications for dry eye disease. Int. J. Mol. Sci. 18, 1–13 (2017).
Yi, X., Wang, Y. & Yu, F. S. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest. Ophthalmol. Vis. Sci. 41, 4093–4100 (2000).
Yap, A. S., Mullin, J. M. & Stevenson, B. R. Molecular analyses of tight junction physiology: insights and paradoxes. J. Membr. Biol. 163, 159–167 (1998).
de Paiva, C. S. et al. Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline. Invest. Ophthalmol. Vis. Sci. 47, 2847–2856 (2006).
Beardsley, R. M., de Paiva, C. S., Power, D. F. & Pflugfelder, S. C. Desiccating stress decreases apical corneal epithelial cell size--modulation by the metalloproteinase inhibitor doxycycline. Cornea 27, 935–940 (2008).
Chauhan, S. K. et al. Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. J. Immunol. 182, 1247–1252 (2009).
Chen, Y., Chauhan, S. K., Tan, X. & Dana, R. Interleukin-7 and -15 maintain pathogenic memory Th17 cells in autoimmunity. J. Autoimmun. 77, 96–103 (2017).
Zhang, X. et al. Interferon-gamma exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest. Ophthalmol. Vis. Sci. 52, 6279–6285 (2011).
Zhang, X. et al. Desiccating stress induces CD4(+) T-cell-mediated Sjogren’s syndrome-like corneal epithelial apoptosis via activation of the extrinsic apoptotic pathway by interferon-gamma. Am. J. Pathol. 179, 1807–1814 (2011).
Wang, C., Kang, S. G., Lee, J., Sun, Z. & Kim, C. H. The roles of CCR6 in migration of Th17 cells and regulation of effector T-cell balance in the gut. Mucosal Immunol. 2, 173–183 (2009).
O’Garra, A., McEvoy, L. M. & Zlotnik, A. T-cell subsets: Chemokine receptors guide the way. Curr. Biol. 8, R646–R649 (1998).
Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803–2812 (2007).
Niederkorn, J. Y. et al. Desiccating stress induces T cell-mediated Sjogren’s syndrome-like lacrimal keratoconjunctivitis. J. Immunol. 176, 3950–3957 (2006).
Coursey, T. G. et al. Age-related spontaneous lacrimal keratoconjunctivitis is accompanied by dysfunctional T regulatory cells. Mucosal Immunol. 10, 743–456 (2017).
de Paiva, C. S. et al. Homeostatic control of conjunctival mucosal goblet cells by NKT-derived IL-13. Mucosal Immunol. 4, 397–408 (2011).
Lemp, M. A., Dohlman, C. H., Kuwabara, T., Holly, F. J. & Carroll, J. M. Dry eye secondary mucus deficiency. Trans. Am. Ophthalmol. Soc. 75, 1223–1227 (1971).
Ralph, R. A. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest. Ophthalmol. 14, 299–302 (1975).
Ko, B. Y., Xiao, Y., Barbosa, F. L., de Paiva, C. S. & Pflugfelder, S. C. Goblet cell loss abrogates ocular surface immune tolerance. JCI Insight. 3, 98222 (2018).
Prakash, S. et al. Dendritic cells from aged subjects contribute to chronic airway inflammation by activating bronchial epithelial cells under steady state. Mucosal Immunol. 7, 1386–1394 (2014).
Manicassamy, S. et al. Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15, 401–409 (2009).
Du, X. et al. An essential role for Rxr alpha in the development of Th2 responses. Eur. J. Immunol. 35, 3414–3423 (2005).
Dohlman, T. H. et al. The CCR6/CCL20 axis mediates Th17 cell migration to the ocular surface in dry eye disease. Invest. Ophthalmol. Vis. Sci. 54, 4081–4091 (2013).
Bian, F. et al. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjogren’s syndrome. Arthritis Res. Ther. 17, 53 (2015).
Zaheer, M. et al. Protective role of commensal bacteria in Sjogren Syndrome. J. Autoimmun. pii: S0896-8411, 30179–30173 (2018).
Coursey, T. G., Bohat, R., Barbosa, F. L., Pflugfelder, S. C. & de Paiva, C. S. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-gamma in experimental dry eye. J. Immunol. 193, 5264–5272 (2014).
Zhang, X. et al. CD8( + ) cells regulate the T helper-17 response in an experimental murine model of Sjogren syndrome. Mucosal Immunol. 7, 417–427 (2014).
Acknowledgements
This work was supported by the NIH EY026893 (C.S.D.P.), NEI Training Grant in Vision Sciences T32 EY007001-41 (H.H.), NIH EY-002520 (Core Grant for Vision Research Department of Ophthalmology), NIH Training Grant T32-AI053831 (F.B.), Pathology Core Laboratory (NCI P30 CA125123), Biology of Inflammation Center (C.S.D.P.), Research to Prevent Blindness, The Oshman Foundation, William Stamps Farish Fund, The Hamill Foundation, The Sid Richardson Foundation, and by Baylor Cytometry and Cell Sorting Core (NIH NIAID P30AI036211, NCI P30CA125123, and NCRR S10RR024574). We thank Brandon Saxton and Joel Sederstrom who provided expert guidance and assistance with flow cytometry experiments, and Leiqi Zhang for expert management of the aged B6 colony.
Author information
Authors and Affiliations
Contributions
C.S.D.P. designed experiments; H.H., Z.Y., R.G.D.S., Y.X., F.B., F.L.B., C.S.D.P. performed experiments; F.B., F.L.B., Y.X., Z.Y., R.G.D.S., H.H. and C.S.D.P. analyzed data; F.B., S.C.P. and C.S.D.P. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This work was presented in part as an abstract at the annual meeting of the Association for Research in Vision and Ophthalmology, Seattle, Washington, USA May 1–5, 2016.
Rights and permissions
About this article
Cite this article
Bian, F., Xiao, Y., Barbosa, F.L. et al. Age-associated antigen-presenting cell alterations promote dry-eye inducing Th1 cells. Mucosal Immunol 12, 897–908 (2019). https://doi.org/10.1038/s41385-018-0127-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41385-018-0127-z
This article is cited by
-
The existence of senescent cells in conjunctival epithelium from elderly individuals
Japanese Journal of Ophthalmology (2024)
-
Immune phenotype of the CD4+ T cells in the aged lymphoid organs and lacrimal glands
GeroScience (2022)
-
Protective effects of low-molecular-weight components of adipose stem cell-derived conditioned medium on dry eye syndrome in mice
Scientific Reports (2021)